Lion Biotechnologies Announces the Departure of Dr. Laszlo Radvanyi Read more about Lion Biotechnologies Announces the Departure of Dr. Laszlo Radvanyi
Lion Biotechnologies Announces Third Quarter 2015 Financial Results Read more about Lion Biotechnologies Announces Third Quarter 2015 Financial Results
Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing Capacity Read more about Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing Capacity
Lion Biotechnologies to Participate in Upcoming Investor Conferences Read more about Lion Biotechnologies to Participate in Upcoming Investor Conferences
Lion Biotechnologies Announces Selection for Addition to NASDAQ Biotechnology Index Read more about Lion Biotechnologies Announces Selection for Addition to NASDAQ Biotechnology Index
Lion Biotechnologies Enters Clinical and Preclinical Research Collaboration With MedImmune Read more about Lion Biotechnologies Enters Clinical and Preclinical Research Collaboration With MedImmune
Lion Biotechnologies Announces Departure of Chief Financial Officer Read more about Lion Biotechnologies Announces Departure of Chief Financial Officer
Lion Biotechnologies Submits Investigational New Drug Application to Conduct Studies in Cervical, Head and Neck Cancer Read more about Lion Biotechnologies Submits Investigational New Drug Application to Conduct Studies in Cervical, Head and Neck Cancer
Lion Biotechnologies Announces Allowance of IND Application to Begin Clinical Trials in Cervical, Head and Neck Cancers Read more about Lion Biotechnologies Announces Allowance of IND Application to Begin Clinical Trials in Cervical, Head and Neck Cancers
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer Read more about Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer